Search results for: 'pfizer'
-
Regenerative Medicine Collaboration and Licensing Deals 2016-2024May 2024$3,995.00
Regenerative Medicine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Licensing Deals in Biotechnology 2019-2024March 2024$3,995.00
Licensing Deals in Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2024
Learn More -
Licensing Deals in Pharmaceuticals 2019-2024March 2024$3,995.00
Licensing Deals in Pharmaceuticals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2024
Learn More -
Collaboration Deals in Biotechnology 2019-2024March 2024$3,995.00
Collaboration Deals in Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2024
Learn More -
Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2016-2023March 2023$3,995.00
The Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2016-2023 report provides comprehensive understanding and unprecedented access to the preclinical stage partnering deals and agreements entered into by the worlds leading healthcare companies
Learn More -
Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2016-2023March 2023$3,995.00
The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2016-2023 report provides comprehensive understanding and unprecedented access to the discovery stage partnering agreements entered into by the worlds leading biopharma companies.
Learn More -
Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2016-2023March 2023$3,995.00
The Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2016-2023 provides comprehensive understanding and unprecedented access to clinical stage partnering agreements entered into by the worlds leading biopharma companies
Learn More